Added to YB: 2021-06-10
Pitch date: 2021-06-10
CNST:US [bullish]
Constellation Pharmaceuticals, Inc.
+1.01%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics to address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance.
Market Cap
$1.6B
Pitch Price
$33.65
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-11.19
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Constellation Pharmaceuticals, Inc. CNST:US
A summary for this pitch has not been created yet.
Read full article (0 min)